These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2260311)

  • 1. [Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition].
    Janicka L; Ksiazek A; Solski J; Majdan M; Bocheńska-Nowacka E; Bednarek-Skublewska A; Spasiewicz D
    Wiad Lek; 1990 Jun; 43(12):564-71. PubMed ID: 2260311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].
    Kuźniak J; Grzegorzewska A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):123-5. PubMed ID: 1437798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An analysis of the effectiveness and benefits of peritoneal dialysis and haemodialysis using Nigerian made PD fluids.
    Arogundade FA; Ishola DA; Sanusi AA; Akinsola A
    Afr J Med Med Sci; 2005 Sep; 34(3):227-33. PubMed ID: 16749353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should dialysis fluid be individualized for the chronic hemodialysis patient? Sodium.
    Flanigan MJ
    Semin Dial; 2008; 21(3):226-9. PubMed ID: 18363598
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent peritoneal dialysis (IPD): an old but still effective modality for severely disabled ESRD patients.
    Fourtounas C; Hardalias A; Dousdampanis P; Savidaki E; Vlachojannis JG
    Nephrol Dial Transplant; 2009 Oct; 24(10):3215-8. PubMed ID: 19515804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].
    Grzegorzewska A; Antoniewicz K; Kuźniak J; Zawadzka E
    Przegl Lek; 1990; 47(10):686-90. PubMed ID: 2089444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal dialysis solutions.
    Gault MH
    Can Med Assoc J; 1973 Feb; 108(3):325-7. PubMed ID: 4691094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
    Kuhlmann MK
    Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
    Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
    J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of various pharmacologic and conventional methods of increasing the effectiveness of peritoneal dialysis. V. Usefulness of selected parameters of peritoneal transfer for evaluating the effectiveness of intermittent peritoneal dialysis].
    Grzegorzewska A
    Przegl Lek; 1989; 46(5):440-7. PubMed ID: 2772244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal fluid agitation and dialysis dose estimation in automatic peritoneal dialysis].
    Esteve V; Ponz E; Marquina D; Blasco C; Martínez Ocaña JC; Mañé N; García M
    Nefrologia; 2006; 26(2):267-9. PubMed ID: 16808266
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal exchange volume and dialysate flow rate in peritoneal dialysis. A clinical study.
    Kalra OP; Abrol L; Chopra JS; Agarwal SK; Prakash C
    J Assoc Physicians India; 1989 Dec; 37(12):762-4. PubMed ID: 2699986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study.
    Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA
    Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].
    Grzegorzewska A; Krzymański M; Antoniewicz K
    Pol Tyg Lek; 1991 Jan 21-28; 46(4-5):67-70. PubMed ID: 1845696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC; Jansen MA; Dekker FW; Boeschoten EW; Krediet RT
    Adv Perit Dial; 1999; 15():132-7. PubMed ID: 10682088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Notes on the electrolytic composition of haemodialysis solutions].
    Ragni R; Segoloni G; Dogliani M; Mangiarotti G; Triolo G
    Arch Sci Med (Torino); 1973; 130(1):1-8. PubMed ID: 17342928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.